Roche pays $1.7 billion for cancer specialist IgnytaRoche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta. The San Diego based Share XRoche pays $1.7 billion for cancer specialist Ignytahttps://pharmaphorum.com/news/roche-pays-1-7-billion-cancer-specialist-ignyta/
After surging on lung cancer data, Ignyta looks to raise $160mSan Diego based biotech firm Ignyta is capping off a week of success with a public stock offering Share XAfter surging on lung cancer data, Ignyta looks to raise $160mhttps://pharmaphorum.com/news/surging-lung-cancer-data-ignyta-looks-raise-160m/
